PureTech Health
Logotype for PureTech Health PLC

PureTech Health (PRTC) investor relations material

PureTech Health 44th Annual J.P. Morgan Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for PureTech Health PLC
44th Annual J.P. Morgan Healthcare Conference summary15 Jan, 2026

Business model and strategy

  • Operates a hub-and-spoke model, spinning out programs into standalone entities to advance therapies and generate financial returns.

  • Focuses on de-risked drug development by targeting validated pharmacology and high unmet medical needs.

  • Portfolio approach enables risk balancing and efficient capital allocation, with no bias toward continuing underperforming programs.

  • Retains equity and non-dilutive economics (royalties, milestones) in spun-out entities, ensuring multiple value streams.

  • Emphasizes continuous innovation, particularly in small molecules and CNS, leveraging prior success and expertise.

Clinical and financial achievements

  • Achieved 80% clinical trial success rate and three FDA-approved treatments, including Cobenfy for schizophrenia.

  • Cobenfy generated over $1.1 billion in gross returns from an $18.5 million investment, with ongoing royalties and milestones valued at ~$300 million through 2033.

  • Seaport Therapeutics spun out, raising $325 million, with PureTech retaining a 35% stake and non-dilutive economics.

  • Self-funded for eight years, maintaining a $320 million balance sheet as of 2025 H1.

Pipeline and upcoming milestones

  • Celea Therapeutics is advancing deupirfenidone, a next-gen antifibrotic for IPF, showing significant efficacy in phase II-B and moving to phase III.

  • Gallop Oncology is developing LYT-200, a novel antibody for AML, showing median overall survival of 13.2 months in phase I, surpassing benchmarks.

  • Seaport Therapeutics has three candidates, two in clinical stage for major depressive and generalized anxiety disorders.

  • Operational priorities for 2026 include securing funding for Gallop and Celea, initiating pivotal trials, and spinning out these programs.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next PureTech Health earnings date

Logotype for PureTech Health PLC
H2 202529 Apr, 2026
PureTech Health
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next PureTech Health earnings date

Logotype for PureTech Health PLC
H2 202529 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

PureTech Health is an American clinical-stage biotherapeutics company that works with the discovery, development, and commercialization of medicines. PureTech’s pipeline includes proprietary product candidates in Phase 2 and Phase 3 clinical development that address significant unmet needs in oncology, central nervous system disorders, inflammatory disease, and gastrointestinal diseases. PureTech has a portfolio of proprietary, investigational medicines that are being developed with leading academic institutions as well as under strategic partnerships with other pharmaceutical companies.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage